Aug 04, 2025
MediSpend Acquires Alucio to Expand AI-Enabled Stakeholder Engagement Capabilities
Jan 27, 2025
MediSpend Expands Its Footprint in Governance, Risk and Compliance Solutions with Acquisition of Real Life Sciences
May 22, 2024
Revolutionizing Commercial Compliance for Life Sciences: MediSpend's Strategic Acquisition of MedCompli
Jan 26, 2021
MediSpend Reports Record-Breaking Year in 2020 Despite COVID-19
Oct 20, 2020
Karyopharm Therapeutics Selects MediSpend's Transparency Solution
Oct 22, 2019
MediSpend Welcomes Seth Houston as Chief Commercial Officer
Oct 21, 2019
MediSpend's VP of Compliance Solutions to Lead Panel of Experts from Corcept and Illumina at 10th Annual CBI Life Sciences West Coast Compliance Congress
Oct 10, 2019
MediSpend's VP of Compliance Solutions to Co-Present with MediSpend Sr Product Manager at 3rd Annual CBI Managing HCP Interactions Conference
Oct 02, 2019
MediSpend Welcomes Dave Cormack to Board of Directors
Sep 04, 2019
MediSpend Names Craig Hauben Chief Executive Officer
Aug 08, 2019
MediSpend's VP of Compliance Solutions to Present at the 13th Annual CBI Forum on Transparency & Aggregate Spend
Jun 17, 2019
MediSpend's CEO & Co-Founder to Present at 10th Annual ExL Aggregate Spend and Open Payments Conference
Apr 15, 2019
MediSpend to Attend Mid-Atlantic CBI Industry Events in April
Mar 25, 2019
MediSpend and Henry Schein to Co-Host Data Analytics Best Practices Webinar
Feb 20, 2019
MediSpend's Legislative Watch Reveals Global Transparency Reporting Insights
Jan 21, 2019
MediSpend's Senior Director of Analytics to Present at the 2nd Annual CBI Data Analytics and Decisions Conference
Oct 18, 2018
MediSpend to Host "Introducing Legislative Watch" Webinar
Sep 10, 2018
MediSpend's Senior Director Analytics to Co-Present with Sanofi at 4th Annual Life Sciences Compliance Congress for Specialty Product Manufacturers
Aug 17, 2018
MediSpend's Senior Director Analytics to Moderate Data Analytics Discussion at 12th Annual Forum on Transparency and Aggregate Spend
Aug 16, 2018
MediSpend to Moderate HCP Interactions Panel at 12th Annual Forum on Transparency and Aggregate Spend